The role of PET imaging in solitary pulmonary nodules

Clinical Pulmonary Medicine

Volumn 16, Issue 2, 2009, Pages 81-88

  Detterbeck, Frank C ^a   Khandani, Amir H ^b  

^a YALE CANCER CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Imaging; PET; Pulmonary nodules; Solitary

Indexed keywords

CANCER RISK; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HUMAN; IMAGE ANALYSIS; LUNG CANCER; LUNG NODULE; POSITRON EMISSION TOMOGRAPHY; REVIEW;

EID: 67650381957     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/CPM.0b013e31819b57c7     Document Type: Review

References (63)

1. Lillington GA. Management of solitary pulmonary nodules. Dis Mon. 1991; 37:271-318.
2. Brenner DJ, Hall EJ. Computed tomography - an increasing source of radiation exposure. N Engl J Med. 2007;357:2277-2284.
3. Gould MK, Fletcher J, Iannettoni MD, et al. Evaluation of patients with pulmonary nodules: when is it lung cancer? ACCP Evidence-based clinical practice guidelines (2nd Edition). Chest. 2007;132:108S-130S.
4. Ost D, Fein AM, Feinsilver SH. The Solitary pulmonary nodule. N Engl J Med. 2003;348:2535-2542.
5. Zerhouni EA, Stitik FP, Siegelman SS, et al. CT of the pulmonary nodule: a cooperative study. Radiology. 1986;160:319-327.
6. Siegelman SS, Khouri NF, Leo FP, et al. Solitary pulmonary nodules: CT assessment. Radiology. 1986;160:307-312.
7. Gurney JW. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I: theory. Radiology. 1993;186:405-413.
8. O'Keefe ME Jr, Good CA, McDonald JR. Calcification in solitary nodules of the lung. Am J Roentgenol. 1957;77:1023-1033.
9. Detterbeck F, Falen S, Rivera M, et al. Seeking a home for a PET, part 1: defining the appropriate place for positron emission tomography imaging in the diagnosis of pulmonary nodules or masses. Chest. 2004;125:2294 -2299.
10. Rivera MP, Mehta AC. Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:131S-148S.
11. Suzuki K, Kusumoto M, Watanabe SI, et al. Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact. Ann Thorac Surg. 2006;81:413-419.
12. Nakamura H, Saji H, Ogata A, et al. Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection. Lung Cancer. 2004;44:61-68.
13. Okada M, Nishio W, Sakamoto T, et al. Discrepancy of computed tomo-graphic image between lung and mediastinal windows as a prognostic implication in small lung adenocarcinoma. Ann Thorac Surg. 2003;76:1828-1832; discussion 1832.
14. Detterbeck F, Gibson C. Turning gray: the natural history of lung cancer over time. J Thorac Oncol. 2008;3:781-792.
15. Murthy SC, Rice TW. The solitary pulmonary nodule: a primer on differential diagnosis. Semin Thorac Cardiovasc Surg. 2002;14:239-249.
16. Sadoff JD, Detterbeck FC. Pulmonary metastases from extrapulmonary cancer. In: Detterbeck FC, Rivera MP, Socinski MA, et al, eds. Diagnosis and Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing Clinician. Philadelphia, PA: WB Saunders; 2001:450-464.
17. Wahidi MM, Govert JA, Goudar RK, et al. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:94S-107S.
18. Detterbeck FC, Rivera MP. Clinical presentation and diagnosis. In: Detter-beck FC, Rivera MP, Socinski MA, et al, eds. Diagnosis and Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing Clinician. Philadelphia, PA: WB Saunders; 2001:45-72.
19. Swensen SJ, Silverstein MD, Ilstrup DM, et al. The probability of malignancy in solitary pulmonary nodules: application to small radiologically indeterminate nodules. Arch Intern Med. 1997;157:849-855.
20. Gould MK, Ananth L, Barnett PG; the Veterans Affairs SCSG. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest. 2007;131:383-388.
21. Rivera MP, Detterbeck FC, Loomis DP. Epidemiology and classification of lung cancer. In: Detterbeck FC, Rivera MP, Socinski MA, et al, eds. Diagnosis and Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing Clinician. Philadelphia, PA: WB Saunders; 2001:25-44.
22. Cummings S, Lillington G, Richard R. Estimating the probability of malignancy in solitary pulmonary nodules: a Bayesian approach. Am Rev Respir Dis. 1986;134:449-452.
23. Herder GJ, van Tinteren H, Golding RP, et al. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-Fluoro-deoxyglucose positron emission tomography. Chest. 2005;128:2490-2496.
24. Schultz EM, Sanders GD, Trotter PR, et al. Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules. Thorax. 2008;63:335-341.
25. Dewan NA, Shehan CJ, Reeb SD, et al. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan. Chest. 1997;112:416-422.
26. Swensen SJ, Silverstein MD, Edell ES, et al. Solitary pulmonary nodules: clinical prediction model versus physicians. Mayo Clin Proc. 1999;74:319-329.
27. Gould MK, Sanders GD, Barnett PG, et al. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med. 2003;138:724-735.
28. Khandani AH, Wahl RL. Applications of PET in liver imaging. Radiol Clin North Am. 2005;43:849-860.
29. Berghmans TD, Dusart M, Paesmans M, et al. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol. 2008;3:6-12.
30. Khandani AH, Rich AW, Qaqish BF, et al. Sensitivity of FDG PET in malignant lung nodules based on non-attenuation corrected images, attenuation corrected images and SUV. In: Annual Meetings of the Society of Nuclear Medicine, 2007. Washington, DC; abstract 260.
31. Hickeson M, Yun M, Matthies A, et al. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET. Eur JNucl Med Mol Imaging. 2002;29:1639-1647.
32. Lowe VJ, Hoffman JM, DeLong DM, et al. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med. 1994;35:1771-1776.
33. Patz EF Jr, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology. 1993; 188:487-490.
34. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology. 1993;189:847-850.
35. Miyauchi T, Wahl RL. Regional 2-[18F]fluoro-2-deoxy-D-glucose uptake varies in normal lung. Eur J Nucl Med Mol Imaging. 1996;23:517-523.
36. Kang W, Chung JK, So Y, et al. Differentiation of mediastinal FDG uptake observed in patients with non-thoracic tumours. Eur J Nucl Med Mol Imaging. 2004;31:202-207.
37. Paquet N, Albert A, Foidart J, et al. Within-patient variability of 18F-FDG: standardized uptake values in normal tissues. J Nucl Med. 2004;45:784-788.
38. Hashimoto Y, Tsujikawa T, Kondo C, et al. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5. J Nucl Med. 2006;47:426-431.
39. Nomori H, Watanabe K, Ohtsuka T, et al. Visual and semiquantitative analyses for F-18 Fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size. Ann Thorac Surg. 2005;79:984-988.
40. Khandani AH, Rich AW, Parker LA, et al. Detectability of malignant lung nodules on FDG PET-CT: impact of attenuation correction on visual interpretation. In: Annual Meetings of the European Association of Nuclear Medicine, 2007. Copenhagen, Denmark. Abstract 242.
41. Bleckmann C, Dose J, Bohuslavizki KH, et al. Effect of attenuation correction on lesion detectability in FDG PET of breast cancer. J Nucl Med. 1999;40: 2021-2024.
42. Bengel FM, Ziegler SI, Avril N, et al. Whole-body positron emission tomography in clinical oncology: comparison between attenuation-corrected and uncorrected images. Eur J Nucl Med Mol Imaging. 1997;24:1091-1098.
43. Gould M, Maclean CC, Kuschner WG, et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta analysis. JAMA. 2001;285:914-924.
44. Fletcher JW, Kymes SM, Gould M, et al. A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. J Nucl Med. 2008;49:179-185.
45. Cummings S, LillingtonG, Richard R. Managing solitary pulmonary nodules: the choice of strategy is a "close call". Am Rev Respir Dis. 1986;134:453-460.
46. Detterbeck F, Falen S, Rivera M, et al. Seeking a home for a PET, Part 2: defining the appropriate place for positron emission tomography imaging in the staging of patients with suspected lung cancer. Chest. 2004;125:2300-2308.
47. Detterbeck F, Jantz M, Wallace M, et al. Invasive mediastinal staging of lung cancer: an ACCP evidence based clinical practice guideline (2nd edition). Chest. 2007;132:202S-220S.
48. Silvestri G, Gould MK, Margolis ML, et al. Non-invasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd Edition). Chest. 2007;132:178S-201S.
49. Herder GJ, Golding RP, Hoekstra OS, et al. The performance of 18F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules. Eur J Nucl Med Mol Imaging. 2004;31:1231-1236.
50. Nomori H, Watanabe K, Ohtsuka T, et al. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer. 2004;45:19-27.
51. Lindell RM, Hartman TE, Swensen SJ, et al. Lung cancer screening experience: a retrospective review of PET in 22 non-small cell lung carcinomas detected on screening chest CT in a high-risk population. Am J Roentgenol. 2005;185:126-131.
52. Port JL, Andrade RS, Levin MA, et al. Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less. J Thorac Cardiovasc Surg. 2005;130:1611-1615.
53. Lowe VJ, Fletcher JW, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol. 1998;16: 1075-1084.
54. Higashi K, Ueda Y, Seki H, et al. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med. 1998;39:1016-1020.
55. Higashi K, Ueda Y, Yagishita M, et al. FDG PET measurement of the proliferative potential of non-small cell lung cancer. J Nucl Med. 2000;41: 85-92.
56. Raz DJ, Odisho AY, Franc BL, et al. Tumor fluoro-2-deoxy-D-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg. 2006;132:1189-1195.
57. Tsunezuka Y, Shimizu Y, Tanaka N, et al. Positron emission tomography in relation to Noguchi's classification for diagnosis of peripheral non-small-cell lung cancer 2 cm or less in size. World J Surg. 2007;31:314-317.
58. Kondo T, Yamada K, Noda K, et al. Radiologic-prognostic correlation in patients with small pulmonary adenocarcinomas. Lung Cancer. 2002;36:49-57.
59. Okada M, Tauchi S, Iwanaga K, et al. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas. J Thorac Cardiovasc Surg. 2007;133:1448-1454.
60. Khandani AH, Whitney KD, Keller SM, et al. Sensitivity of FDG PET, GLUT1 expression and proliferative index in bronchioloalveolar lung cancer. Nucl Med Commun. 2007;28:173-177.
61. Detterbeck FC, Vansteenkiste JF, Morris DE, et al. Seeking a home for a PET, Part 3: emerging applications of positron emission tomography imaging in the management of patients with lung cancer. Chest. 2004;126:1656-1666.
62. Pastorino U, Bellomi M, Landoni C, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet. 2003;362:593-597.
63. Vesselle H, Schmidt RA, Pugsley JM, et al. Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res. 2000;6:3837-3844.